Identification of m5C-Related gene diagnostic biomarkers for sepsis: a machine learning study
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Machine-learning selection identifies three m5C-related sepsis biomarkers with diagnostic performance in test and validation sets (AUC >0.7). This is a specific disease classification result, limited to retrospective datasets.
Technology: Original Methods examined; model operation and its relationship to the stated result are described in the source.
Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Original Methods examined; model operation and its relationship to the stated result are described in the source.
- Limitation / still unknown
- The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/fgene/articles/10.3389/fgene.2024.1444003/full · https://pubmed.ncbi.nlm.nih.gov/39540021/
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.